ANISODAMINE
|
|
|
- CAS-Nr.
- 55869-99-3
- Englisch Name:
- ANISODAMINE
- Synonyma:
- 6-hydroxyhyoscyamine;aceanisodaMine;(-)-Anisodamine;Atropine impurity E;6-hydroxy-hyoscyamin;Apoatropine Impurity E;6-β-Hydroxyhyoscyamine;Scopolamine Impurity 6;6-beta-hydroxyhyoscyamine;Hyoscyamine EP Impurity C
- CBNumber:
- CB9354311
- Summenformel:
- C17H23NO4
- Molgewicht:
- 305.37
- MOL-Datei:
- 55869-99-3.mol
|
ANISODAMINE Eigenschaften
- Schmelzpunkt:
- 62-63 °C
- Siedepunkt:
- 474.6±45.0 °C(Predicted)
- Dichte
- 1.27
- storage temp.
- room temp
- Löslichkeit
- H2O: ≥5mg/mL
- pka
- 14.12±0.10(Predicted)
- Aggregatzustand
- powder
- Farbe
- white to beige
ANISODAMINE Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
6S-Hydroxyhyoscyamine is a derivative of Hyoscyamine (H674300), a natural compound that has inhibitory activity against cholinesterases.
Allgemeine Beschreibung
Racemic mixture of diastereomers.
Biochem/physiol Actions
Anisodamine is a non‐specific cholinergic antagonist. It is considered less efficient and less toxic than atropine. Anisodamine interferes with liposome structure and affects cell membrane. It might act as an anti‐oxidant, in protecting against the damage caused by free radicals. Anisodamine is known to reduce cardiac conduction and also prevents arrhythmia. It can block thromboxane synthesis and might possess anti‐thrombotic function. Anisodamine has been useful in a number therapies including septic shock, circulatory disorders, organophosphorus poisoning, opiate addiction, snake bite and radiation damage. Disorders, such as migraine, gastric ulcers, rheumatoid arthritis, gastrointestinal colic, eclampsia, respiratory diseases, acute glomerular nephritis and obstructive jaundice can be treated with the help of anisodamine.
ANISODAMINE Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
ANISODAMINE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 96)Lieferanten
55869-99-3()Verwandte Suche:
- (1r-(1-alpha,3-beta(s*),5-alpha,6-alpha))-.1)oct-3-yleste
- Atropine impurity E
- Hyoscyamine, 6-hydroxy- (6ci, 7ci)
- aceanisodaMine
- Atropine iMpurity E (7-hydroxyhyoscyaMine)
- 6-beta-hydroxyhyoscyamine
- 6-hydroxy-hyoscyamin
- alpha-(hydroxymethyl)-benzeneaceticaci6-hydroxy-8-methyl-8-azabicyclo(3.2
- (αS)-α-(Hydroxymethyl)benzeneacetic acid (1R,5R)-6β-hydroxy-8-methyl-8-azabicyclo[3.2.1]oct-3α-yl ester
- (αS)-α-(Hydroxymethyl)benzeneacetic acid (1R,5R)-6β-hydroxy-8-methyl-8-azabicyclo[3.2.1]octa-3α-yl ester
- (αS)-α-Hydroxymethylbenzeneacetic acid (1β,5β)-6β-hydroxy-8-methyl-8-azabicyclo[3.2.1]octane-3α-yl ester
- [S,(-)]-α-(Hydroxymethyl)benzeneacetic acid (1R,5R)-6β-hydroxy-8-methyl-8-azabicyclo[3.2.1]octane-3α-yl ester
- alpha-(Hydroxymethyl)benzeneacetic acid 6-hydroxy-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester
- Benzeneacetic acid, alpha-(hydroxymethyl)-, (1R,3S,5R,6S)-6-hydroxy-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, (alphas)-
- Benzeneacetic acid, alpha-(hydroxymethyl)-, 6-hydroxy-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, (1R-(1-alpha,3-beta(S*),5-alpha,6-alpha))-
- Atropine Impurity 5（Atropine EP Impurity E）
- (1R,3S,5R,6RS)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate
- Hyoscyamine Sulfate Impurity 3（Hyoscyamine Sulfate EP Impurity C）
- Hyoscyamine EP Impurity C
- Benzeneacetic acid, α-(hydroxymethyl)-, (1R,3S,5R,6S)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (αS)-
- Atropine EP Impurity E (Mixture of Diastereomers) (7-Hydroxyhyoscyamine)
- 6(S)-HydroxyhyoscyamineDiscontinued See H942900
- (-)-Anisodamine
- Apoatropine Impurity E
- Anisodamine (6-hydroxy Hyoscyamine)
- 6-β-Hydroxyhyoscyamine
- 6-β-Hydroxyhyoscyamine Acetate saltQ: What is
6-β-Hydroxyhyoscyamine Acetate salt Q: What is the CAS Number of
6-β-Hydroxyhyoscyamine Acetate salt
- 6-hydroxyhyoscyamine
- Atropine EP Impurity E(7-Hydroxyhyoscyamine)
- (1R,3S,5R)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2S)-3-hydroxy-2-phenylpropanoate
- Scopolamine Impurity 6
- 55869-99-3
- 55869-95-3
